1. Home
  2. IMMP vs LAW Comparison

IMMP vs LAW Comparison

Compare IMMP & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • LAW
  • Stock Information
  • Founded
  • IMMP 1987
  • LAW 2013
  • Country
  • IMMP Australia
  • LAW United States
  • Employees
  • IMMP N/A
  • LAW N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • LAW Computer Software: Prepackaged Software
  • Sector
  • IMMP Health Care
  • LAW Technology
  • Exchange
  • IMMP Nasdaq
  • LAW Nasdaq
  • Market Cap
  • IMMP 211.1M
  • LAW 209.5M
  • IPO Year
  • IMMP N/A
  • LAW 2021
  • Fundamental
  • Price
  • IMMP $1.86
  • LAW $3.98
  • Analyst Decision
  • IMMP Buy
  • LAW Hold
  • Analyst Count
  • IMMP 2
  • LAW 3
  • Target Price
  • IMMP $8.50
  • LAW $6.17
  • AVG Volume (30 Days)
  • IMMP 648.0K
  • LAW 78.1K
  • Earning Date
  • IMMP 05-16-2025
  • LAW 05-07-2025
  • Dividend Yield
  • IMMP N/A
  • LAW N/A
  • EPS Growth
  • IMMP N/A
  • LAW N/A
  • EPS
  • IMMP N/A
  • LAW N/A
  • Revenue
  • IMMP $3,019,249.00
  • LAW $145,923,000.00
  • Revenue This Year
  • IMMP $11.25
  • LAW $5.10
  • Revenue Next Year
  • IMMP $10.22
  • LAW $5.18
  • P/E Ratio
  • IMMP N/A
  • LAW N/A
  • Revenue Growth
  • IMMP 24.11
  • LAW 3.84
  • 52 Week Low
  • IMMP $1.32
  • LAW $3.31
  • 52 Week High
  • IMMP $3.34
  • LAW $8.20
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 53.43
  • LAW 57.80
  • Support Level
  • IMMP $1.44
  • LAW $3.49
  • Resistance Level
  • IMMP $2.71
  • LAW $3.84
  • Average True Range (ATR)
  • IMMP 0.17
  • LAW 0.15
  • MACD
  • IMMP 0.05
  • LAW 0.06
  • Stochastic Oscillator
  • IMMP 29.75
  • LAW 97.10

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

Share on Social Networks: